Ticker Search:  Getting Started | Register | Videos | Newsletter | Partners | Login    

Basics
Axon Holdings S.A.
Axovant Sciences Ltd is a clinical-stage biopharmaceutical company focused on the acquisition, development and commercialization of novel therapeutics for the treatment of dementia.
IPO Date: June 11, 2015
Sector: Industrials
Industry: Aerospace and Defense
Market Cap: $58.07B
Activated in VL: True
Average Daily Range
Avg Daily Range: $2.60 | 2.43%
Avg Daily Range (30 D): $13.01 | 1.66%
Avg Daily Range (90 D): $11.75 | 1.81%
Institutional Daily Volume
Avg Daily Volume: .62M
Avg Daily Volume (30 D): .43M
Avg Daily Volume (90 D): .45M
Trade Size
Avg Trade Size (Sh.): 77
Avg Trade Size (Sh.) (30 D): 18
Avg Trade Size (Sh.) (90 D): 20
Institutional Trades
Total Inst.Trades: 3,179
Avg Inst. Trade: $14.31M
Avg Inst. Trade (30 D): $47.63M
Avg Inst. Trade (90 D): $35.75M
Avg Inst. Trade Volume: .06M
Avg Inst. Trades (Per Day): 2
Market Closing Trades
Avg Closing Trade: $24.6M
Avg Closing Trade (30 D): $73.36M
Avg Closing Trade (90 D): $62.83M
Avg Closing Volume: 85.09K
   
News
Jul 8, 2025 @ 11:05 AM
10 Monster Stocks to Hold for the Next 10 Years
Source: James Brumley
Jun 13, 2025 @ 5:02 PM
ICE Raids and Civil Unrest Fuel Investor Surge in ...
Source: Jaime Catmull
Jun 8, 2025 @ 7:32 AM
2 High-Growth Stocks to Buy and Hold for Great Lon...
Source: John Ballard
Jun 2, 2025 @ 3:39 PM
AXON: Competition Intensifies as Motorola Makes $4...
Source: Marketbeat.Com
May 15, 2025 @ 1:12 PM
Is Axon Stock Too Expensive—or Just Getting...
Source: Marketbeat.Com
Financials
  TTM Q3 2024 Q2 2024
Basic EPS $1.14 $.89 $.55
Diluted EPS $1.08 $.86 $.53
Revenue $ 603.63M $ 544.27M $ 503.24M
Gross Profit $ 365.74M $ 330.75M $ 306.16M
Net Income / Loss $ 87.98M $ 67.03M $ 41.47M
Operating Income / Loss $ -8.79M $ 24.08M $ 33.76M
Cost of Revenue $ 237.89M $ 213.53M $ 197.08M
Net Cash Flow $ 638M $ 128.84M $ 162.61M
PE Ratio 658.49    
Splits
Sep 28, 2007:   1:600
Nov 30, 2004:   2:1
Apr 30, 2004:   2:1
Feb 11, 2004:   3:1